These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33809767)

  • 1. Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?
    Navarro-Zaragoza J; Cuenca-Bermejo L; Almela P; Laorden ML; Herrero MT
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity.
    Cox D; Whiten DR; Brown JWP; Horrocks MH; San Gil R; Dobson CM; Klenerman D; van Oijen AM; Ecroyd H
    J Biol Chem; 2018 Mar; 293(12):4486-4497. PubMed ID: 29382725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27.
    Hayashi J; Ton J; Negi S; Stephens DEKM; Pountney DL; Preiss T; Carver JA
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 70 reduces α-synuclein-induced predegenerative neuronal dystrophy in the α-synuclein viral gene transfer rat model of Parkinson's disease.
    Moloney TC; Hyland R; O'Toole D; Paucard A; Kirik D; O'Doherty A; Gorman AM; Dowd E
    CNS Neurosci Ther; 2014 Jan; 20(1):50-8. PubMed ID: 24279716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small heat shock proteins αB-crystallin (HSPB5) and Hsp27 (HSPB1) inhibit the intracellular aggregation of α-synuclein.
    Cox D; Ecroyd H
    Cell Stress Chaperones; 2017 Jul; 22(4):589-600. PubMed ID: 28337642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Heat-shock Proteins Prevent α-Synuclein Aggregation via Transient Interactions and Their Efficacy Is Affected by the Rate of Aggregation.
    Cox D; Selig E; Griffin MD; Carver JA; Ecroyd H
    J Biol Chem; 2016 Oct; 291(43):22618-22629. PubMed ID: 27587396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson's disease.
    Aghazadeh N; Beilankouhi EAV; Fakhri F; Gargari MK; Bahari P; Moghadami A; Khodabandeh Z; Valilo M
    Mol Biol Rep; 2022 Nov; 49(11):11061-11070. PubMed ID: 36097120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease.
    Arkan S; Ljungberg M; Kirik D; Hansen C
    Neurobiol Dis; 2021 Oct; 158():105477. PubMed ID: 34390836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential application of heat shock proteins as therapeutic targets in Parkinson's disease.
    Guo H; Yi J; Wang F; Lei T; Du H
    Neurochem Int; 2023 Jan; 162():105453. PubMed ID: 36402293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
    Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
    Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp27 suppresses the Cu(2+)-induced amyloidogenicity, redox activity, and cytotoxicity of α-synuclein by metal ion stripping.
    Asthana A; Bollapalli M; Tangirala R; Bakthisaran R; Mohan Rao Ch
    Free Radic Biol Med; 2014 Jul; 72():176-90. PubMed ID: 24746619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.
    Shen QQ; Jv XH; Ma XZ; Li C; Liu L; Jia WT; Qu L; Chen LL; Xie JX
    Acta Pharmacol Sin; 2024 Feb; 45(2):268-281. PubMed ID: 37674042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and propagation of α-synuclein aggregation in the nervous system.
    Hijaz BA; Volpicelli-Daley LA
    Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.